Drug intelligence / Profile preview

Guilu Erxian

Development stage: Unknown
Lead developer: Dong-E-E-Jiao
Administration: Oral

Overview

Guilu Erxian is a Traditional Chinese Medicine (TCM) formula traditionally used to treat syndromes associated with kidney yang deficiency and essence-blood depletion. It typically comprises four primary ingredients: deer antler (*Cornu Cervi*), tortoise shell (*Carapax et Plastrum Testudinis*), ginseng (*Panax ginseng*), and wolfberry (*Lycium barbarum*). In modern clinical development, Shandong Dong'e Ejiao Co., Ltd. is evaluating an oral liquid formulation for the treatment of psychogenic erectile dysfunction. The formula is believed to work by tonifying the kidneys, replenishing essence, and strengthening yang, thereby addressing the underlying physiological and psychological components of sexual dysfunction in the context of TCM theory.

Other names: Guilu Erxian JiaoGuilu Erxian WanGuilu Erxian Oral Liquid

Beyond the preview

Go deeper on Guilu Erxian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guilu Erxian.

Explore the full profile